NasdaqCM - Delayed Quote USD
Cyclacel Pharmaceuticals, Inc. (CYCC)
0.2302
+0.0046
+(2.04%)
At close: April 23 at 4:00:00 PM EDT
0.2300
-0.00
(-0.09%)
After hours: April 23 at 7:46:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -2.27 | -26.75 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -6.35 | -4.93 | -1.43 | -0.54 |
| EPS Actual | -6.23 | -2.27 | -0.72 | -0.18 |
| Difference | 0.12 | 2.66 | 0.72 | 0.36 |
| Surprise % | 1.89% | 53.96% | 49.83% | 66.67% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CYCC | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Maintains | Roth MKM: Buy to Buy | 5/3/2024 |
| Downgrade | Brookline Capital: Buy to Hold | 12/19/2023 |
| Maintains | Roth MKM: Buy to Buy | 12/19/2023 |
Related Tickers
KLTO Klotho Neurosciences, Inc.
0.1515
-2.88%
NKGN NKGen Biotech, Inc.
0.1223
+9.29%
VIRX Viracta Therapeutics, Inc.
0.0173
+1.76%
OABIW OmniAb, Inc.
0.3015
0.00%
4DN.F Denali Therapeutics Inc.
12.88
+13.24%
4SG.F Sol-Gel Technologies Ltd.
0.5900
+32.88%
1S9.SG Seres Therapeutics Inc
6.43
0.00%
ADIL Adial Pharmaceuticals, Inc.
0.7001
+3.29%
EYEN Eyenovia, Inc.
1.0901
+0.01%
GLMD Galmed Pharmaceuticals Ltd.
1.6300
+10.88%